Description

Orenetide is an innovative peptide drug developed in the study to restore sexual desire and concomitant functions in women with HSDD (Hypoactive desire disorder)[1]—–C26H47N9O7—-[1]Sukhikh G.T., et al. Orenetide for the treatment of hypoactive sexual desire disorder: results of a randomized placebo-controlled trial. Obstetrics and Gynegology. 2022–1124168-43-9–597.71—-O=C(N(CCC1)[C@@H]1C(N[C@@H](CCCNC(N)=N)C(N(CCC2)[C@@H]2C(O)=O)=O)=O)[C@H](CCCCN)NC([C@@H](N)[C@H](O)C)=O–Endocrinology–10 mM in DMSO–Others—-Others–Peptides